SECRETIVE SECRETIONS, EXPLOSIVE EXCRETIONS

INTRODUCTION/BACKGROUND Vasoactive Intestinal Peptide (VIP)-secreting neuroendo- crine tumours (VIPomas) are rare, usually presenting with profuse watery diarrhea leading to severe electrolyte imbalances. Our patient’s initial presentation with obstructive jaundice and portal vein thrombosis preceded the typical presentation, complicating early diagnosis. CASE A 34-year-old male presented in May 2024 with progressive jaundice, tea-colored urine and pale stools but no diarrhea. Investigations revealed markedly elevated direct hyperbilirubinemia (205 µmol/L), alkaline phosphatase (742 U/L) and gamma-glutamyl transferase (612 U/L), which was suggestive of biliary obstruction. CT scan identified a 4.2 cm pancreatic mass with hepatic metastases and portal vein thrombosis. EUS visualized a hypoechoic lesion at the head of the pancreas measuring 38 x 35 mm, causing upstream dilatation of the pancreatic and common bile duct. ERCP was done for sphincterectomy and stenting. Histopathology revealed a low-grade neuroendocrine neoplasm. Six months later, the patient developed persistent watery diarrhea for two weeks, along with fatigue and weight loss. His severe hypokalemia (as low as 1.5 mmol/L) was refractory despite 3 days of intravenous potassium infusion. Stool studies excluded infective causes, and 24-hour urine 5-HIAA was normal. Trial of subcutaneous octreotide, titrated up to 100 mcg, led to resolution of symptoms and hypokalaemia within a day. His fasting serum VIP levels sent prior to initiation of therapy were elevated at 211 pg/ml (normal range <86 pg/ mL). Gallium-68 DOTATATE showed somatostatin-avid disease at the pancreatic head, multiple abdominopelvic lymph nodes and both liver lobes. Our multidisciplinary team meeting determined that curative surgery was not feasible due to extensive metastases and vascular involvement. The patient remains well and asymptomatic on octreotide long-acting release during subsequent follow-ups. CONCLUSION This case highlights an unusual case of VIPoma, which presented with cholestatic jaundice prior to diarrhea. Strong multidisciplinary collaboration is crucial to optimize outcomes.

Authors

Publication Details

Journal
Journal of the ASEAN Federation of Endocrine Societies
Published
2025-05-30
DOI
https://doi.org/10.15605/jafes.040.s1.034
Primary Topic
Neuroendocrine Tumor Research Advances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SECRETIVE SECRETIONS, EXPLOSIVE EXCRETIONS

Siew C. Ng, Kayla Chiew
Journal of the ASEAN Federation of Endocrine Societies
Neuroendocrine Tumor Research Advances
article

SECRETIVE SECRETIONS, EXPLOSIVE EXCRETIONS

Siew C. Ng, Kayla Chiew
article en

Abstract

INTRODUCTION/BACKGROUND Vasoactive Intestinal Peptide (VIP)-secreting neuroendo- crine tumours (VIPomas) are rare, usually presenting with profuse watery diarrhea leading to severe electrolyte imbalances. Our patient’s initial presentation with obstructive jaundice and portal vein thrombosis preceded the typical presentation, complicating early diagnosis. CASE A 34-year-old male presented in May 2024 with progressive jaundice, tea-colored urine and pale stools but no diarrhea. Investigations revealed markedly elevated direct hyperbilirubinemia (205 µmol/L), alkaline phosphatase (742 U/L) and gamma-glutamyl transferase (612 U/L), which was suggestive of biliary obstruction. CT scan identified a 4.2 cm pancreatic mass with hepatic metastases and portal vein thrombosis. EUS visualized a hypoechoic lesion at the head of the pancreas measuring 38 x 35 mm, causing upstream dilatation of the pancreatic and common bile duct. ERCP was done for sphincterectomy and stenting. Histopathology revealed a low-grade neuroendocrine neoplasm. Six months later, the patient developed persistent watery diarrhea for two weeks, along with fatigue and weight loss. His severe hypokalemia (as low as 1.5 mmol/L) was refractory despite 3 days of intravenous potassium infusion. Stool studies excluded infective causes, and 24-hour urine 5-HIAA was normal. Trial of subcutaneous octreotide, titrated up to 100 mcg, led to resolution of symptoms and hypokalaemia within a day. His fasting serum VIP levels sent prior to initiation of therapy were elevated at 211 pg/ml (normal range <86 pg/ mL). Gallium-68 DOTATATE showed somatostatin-avid disease at the pancreatic head, multiple abdominopelvic lymph nodes and both liver lobes. Our multidisciplinary team meeting determined that curative surgery was not feasible due to extensive metastases and vascular involvement. The patient remains well and asymptomatic on octreotide long-acting release during subsequent follow-ups. CONCLUSION This case highlights an unusual case of VIPoma, which presented with cholestatic jaundice prior to diarrhea. Strong multidisciplinary collaboration is crucial to optimize outcomes.

Journal of the ASEAN Federation of Endocrine SocietiesVol. 40(S1)
Openalex Percentile: Top 82%
Neuroendocrine Tumor Research Advances
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.